BLACK DIAMOND THERAPEUTICS, INC. Variable Lease, Cost
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Variable Lease, Cost of $228.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-05
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-06-30 was $228.00K, a 0.44% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for the quarter ending 2026-03-31 was $213.00K, a 17.76% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-12-31 was $259.00K, a 8.37% increase year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for the quarter ending 2025-09-30 was $259.00K, a 9.28% increase year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for fiscal 2025 was $1.01M, a 9.95% increase from fiscal 2024.
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for fiscal 2024 was $915.00K, a 6.40% increase from fiscal 2023.
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for fiscal 2023 was $860.00K, a 15.02% decline from fiscal 2022.
- BLACK DIAMOND THERAPEUTICS, INC. variable lease, cost for fiscal 2022 was $1.01M, a 127.93% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $228.00K 10-Q · filed 2026-08-05 | $441.00K 10-Q · filed 2026-08-05 | $700.00K derived: sum of 3 quarters · filed 2026-08-05 | $959.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $213.00K 10-Q · filed 2026-05-07 | $472.00K derived: sum of 2 quarters · filed 2026-05-07 | $731.00K derived: sum of 3 quarters · filed 2026-05-07 | $960.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $518.00K derived: sum of 2 quarters · filed 2026-03-16 | $747.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.01M 10-K · filed 2026-03-16 |
| 2025-09-30 | $259.00K 10-Q · filed 2025-11-06 | $488.00K derived: sum of 2 quarters · filed 2026-08-05 | $747.00K 10-Q · filed 2025-11-06 | $986.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $229.00K 10-Q · filed 2026-08-05 | $488.00K 10-Q · filed 2026-08-05 | $727.00K derived: sum of 3 quarters · filed 2026-08-05 | $964.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $259.00K 10-Q · filed 2026-05-07 | $498.00K derived: sum of 2 quarters · filed 2026-05-07 | $735.00K derived: sum of 3 quarters · filed 2026-05-07 | $937.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $476.00K derived: sum of 2 quarters · filed 2026-03-16 | $678.00K derived: sum of 3 quarters · filed 2026-03-16 | $915.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $237.00K 10-Q · filed 2025-11-06 | $439.00K derived: sum of 2 quarters · filed 2025-11-06 | $676.00K 10-Q · filed 2025-11-06 | $908.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $202.00K 10-Q · filed 2025-08-07 | $439.00K 10-Q · filed 2025-08-07 | $671.00K derived: sum of 3 quarters · filed 2025-08-07 | $917.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $237.00K 10-Q · filed 2025-05-12 | $469.00K derived: sum of 2 quarters · filed 2025-05-12 | $715.00K derived: sum of 3 quarters · filed 2025-05-12 | $841.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $478.00K derived: sum of 2 quarters · filed 2025-03-06 | $604.00K derived: sum of 3 quarters · filed 2025-03-06 | $860.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $246.00K 10-Q · filed 2024-11-05 | $372.00K derived: sum of 2 quarters · filed 2024-11-05 | $628.00K 10-Q · filed 2024-11-05 | $923.00K derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $126.00K 10-Q · filed 2024-08-06 | $382.00K 10-Q · filed 2024-08-06 | $677.00K derived: sum of 3 quarters · filed 2024-08-06 | $918.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $256.00K 10-Q · filed 2024-05-09 | $551.00K derived: sum of 2 quarters · filed 2024-05-09 | $792.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.01M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $295.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $536.00K derived: sum of 2 quarters · filed 2024-03-12 | $755.00K derived: sum of 3 quarters · filed 2024-03-12 | $1.01M 10-K · filed 2024-03-12 |
| 2022-09-30 | $241.00K 10-Q · filed 2023-11-06 | $460.00K derived: sum of 2 quarters · filed 2023-11-06 | $717.00K 10-Q · filed 2023-11-06 | $949.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $219.00K 10-Q · filed 2023-08-11 | $476.00K 10-Q · filed 2023-08-11 | $708.00K derived: sum of 3 quarters · filed 2023-08-11 | $844.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $257.00K 10-Q · filed 2023-05-09 | $489.00K derived: sum of 2 quarters · filed 2023-05-09 | $625.00K derived: sum of 3 quarters · filed 2023-05-09 | $668.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $368.00K derived: sum of 2 quarters · filed 2023-03-09 | $411.00K derived: sum of 3 quarters · filed 2023-03-09 | $444.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $136.00K 10-Q · filed 2022-11-08 | $179.00K derived: sum of 2 quarters · filed 2022-11-08 | $212.00K 10-Q · filed 2022-11-08 | $225.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $43.00K 10-Q · filed 2022-08-09 | $76.00K 10-Q · filed 2022-08-09 | $89.00K derived: sum of 3 quarters · filed 2022-08-09 | $98.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-11 | $46.00K derived: sum of 2 quarters · filed 2022-05-11 | $55.00K derived: sum of 3 quarters · filed 2022-05-11 | $65.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $22.00K derived: sum of 2 quarters · filed 2022-03-17 | $32.00K derived: sum of 3 quarters · filed 2022-03-17 | $44.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $9.00K 10-Q · filed 2020-11-10 | $19.00K derived: sum of 2 quarters · filed 2020-11-10 | $31.00K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $10.00K 10-Q · filed 2020-08-11 | $22.00K 10-Q · filed 2020-08-11 | ||
| 2020-03-31 | $12.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |